Corvus Pharmaceuticals Inc (CRVS)
1.45
-0.03
(-2.03%)
USD |
NASDAQ |
Apr 26, 16:00
1.47
+0.02
(+1.38%)
After-Hours: 20:00
Corvus Pharmaceuticals Cash from Operations (TTM): -23.94M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.94M |
| September 30, 2023 | -26.32M |
| June 30, 2023 | -27.81M |
| March 31, 2023 | -28.71M |
| December 31, 2022 | -27.02M |
| September 30, 2022 | -26.33M |
| June 30, 2022 | -27.83M |
| March 31, 2022 | -34.35M |
| December 31, 2021 | -36.72M |
| September 30, 2021 | -38.07M |
| June 30, 2021 | -37.37M |
| March 31, 2021 | -34.21M |
| December 31, 2020 | -34.78M |
| September 30, 2020 | -35.08M |
| June 30, 2020 | -37.96M |
| March 31, 2020 | -37.68M |
| December 31, 2019 | -37.32M |
| Date | Value |
|---|---|
| September 30, 2019 | -37.07M |
| June 30, 2019 | -37.26M |
| March 31, 2019 | -38.93M |
| December 31, 2018 | -40.99M |
| September 30, 2018 | -43.71M |
| June 30, 2018 | -43.69M |
| March 31, 2018 | -44.51M |
| December 31, 2017 | -46.21M |
| September 30, 2017 | -44.64M |
| June 30, 2017 | -40.55M |
| March 31, 2017 | -34.97M |
| December 31, 2016 | -27.86M |
| September 30, 2016 | -22.39M |
| June 30, 2016 | -19.06M |
| March 31, 2016 | -14.64M |
| December 31, 2015 | -11.33M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-38.07M
Minimum
Sep 2021
-23.94M
Maximum
Dec 2023
-32.94M
Average
-34.78M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
| Cyclacel Pharmaceuticals Inc | -16.11M |
| Arbutus Biopharma Corp | -85.94M |
| Oragenics Inc | -7.291M |
| Relmada Therapeutics Inc | -51.66M |
| MAIA Biotechnology Inc | -13.07M |